Seoul Court accepted interim injunction on test fraud case.

The Seoul District Administrative Court has accepted the interim injunction earlier raised by 12 pharmaceutical companies against the KFDA's cancellation and scrap of the product health registration on charge of the manipulated bio equivalency tests.

Now, the KFDA's administrative measures of the product registration cancellation and scrap against the drugs produced by 12 local companies on ...